骨科医生对美国国立卫生研究院资助髋膝关节置换研究的影响
BACKGROUND: The National Institutes of Health (NIH) remains one of the predominant sources of biomedical research funding in the United States, yet its impact on total hip and knee arthroplasty research is poorly understood.…
要点
- 骨科医生作为主要研究者的比例仅为16.0%(20人),而骨外科系获得的资助占比最高(23.5%)。
- 资助领域以术后并发症(44.4%)、术后疼痛管理(17.6%)和康复(15.1%)为主。
核心结论
- NIH资助的髋膝关节置换研究中骨科医生作为主要研究者的代表性不足,骨科医生可能在已识别的临床兴趣领域存在合作机会。
- 需要进一步研究以了解骨科医生主要研究者获得NIH资助的障碍。
研究设计与样本
- 研究查询了NIH的RePORTER数据库,纳入2010年至2020年资助的髋膝关节置换相关项目及NIH总资助额,计算复合年增长率,并与20个其他临床领域比较,采用Student t检验进行组间比较。
主要发现
- R01资助机制占主导(63.1%),Mayo Clinic(罗切斯特,明尼苏达州)获得资助最多(9.7%),骨外科系获得资助占比最高(23.5%),但仅20名骨科医生被确定为主要研究者(16.0%)。
- 按主要研究者人口学和学术特征比较NIH资助总额无显著差异(p > 0.05),但骨科医生的Hirsch指数(h指数)属于最高之列(p < 0.001)。
- 资助支持临床研究(63.5%)、转化研究(19.3%)、基础科学(7.1%)和其他类型(10.1%);资助最多的领域为术后并发症(44.4%)、术后疼痛管理(17.6%)、康复(15.1%)和植入物设计(12.4%)。
临床怎么用
- 原文未据此给出推荐。
- 作者认为增加NIH资助是骨外科系的战略优先事项,了解全关节置换各临床领域的资助水平对于促进NIH的研究和发现支持至关重要。
局限性
- 需要进一步研究以了解骨科医生主要研究者获得NIH资助的障碍。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The National Institutes of Health (NIH) remains one of the predominant sources of biomedical research funding in the United States, yet its impact on total hip and knee arthroplasty research is poorly understood. This study defines the portfolio of NIH funding for total joint arthroplasty (TJA) and the impact of orthopaedic surgeons on this portfolio. METHODS: The Research Portfolio Online Reporting Tools Expenditures and Results (RePORTER) database was queried for NIH grants that had been awarded for total hip and knee arthroplasty and total NIH funding from 2010 to 2020. Compound annual growth rates (CAGRs) were calculated. Funding totals were compared with those from 20 other clinical areas. The principal investigators (PIs) and grants were characterized, and comparisons were made with use of the Student t test. RESULTS: A total of 489 grants were awarded, totaling $181 million (CAGR of 10.3%). This was >3 times the growth rate for the total NIH budget (CAGR of 2.9%), which increased from $31.2 to $41.7 billion over the 11-year period. When compared with 20 other clinical areas, TJA received the least amount of NIH funding over that period. Alzheimer disease received the most funding ($12.1 billion, CAGR of 19.5%), and cerebral palsy received the penultimate amount of funding ($284 million, CAGR of 6.3%). The R01 grant mechanism was the predominant source (63.1%), and the Mayo Clinic (Rochester, Minnesota) received the most funding (9.7%). Departments of orthopaedic surgery were awarded the most funding (23.5%), yet only 20 orthopaedic surgeons were identified as PIs (16.0%). There were no significant differences in NIH funding totals by PI demographic and academic characteristics (p > 0.05), yet orthopaedic surgeons had among the highest Hirsch indices (h-indices) (p < 0.001). Funding supported clinical (63.5%), translational (19.3%), basic science (7.1%), and other types (10.1%) of research. The top areas with funding were postoperative complications (44.4%), postoperative pain management (17.6%), rehabilitation (15.1%), and implant design (12.4%). CONCLUSIONS: There is a paucity of orthopaedic surgeon representation among NIH grants awarded for TJA. Opportunities may exist for orthopaedic surgeons to collaborate in identified areas of clinical interest. Additional research is needed to understand the obstacles to obtaining NIH grant funding for orthopaedic surgeon PIs. CLINICAL RELEVANCE: Increasing the levels of funding from the NIH is a strategic priority for departments of orthopaedic surgery. Understanding levels of funding for clinical areas in total joint arthroplasty is critical to foster research and discovery support from the NIH.
引用
- Silvestre J, Martinez R, Thompson TL, et al. Impact of Orthopaedic Surgeons on National Institutes of Health Funding for Hip and Knee Arthroplasty Research. J Bone Joint Surg Am. 2022. PMID: 36476739. doi:10.2106/JBJS.22.00025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。